triazolam
Ligand Summary
A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
UNII: 1HM943223R
PubChem: 5556
Guide to Pharmacology: 7313
ChEMBL: CHEMBL646
DrugCentral: 2729
LyCHI: LLG5LABAKL51
Target Activities
52 Activities
Items per page:
1 – 10 of 52
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | ||||||
Kd | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Kd | ||||||
Kd | ||||||
Kd | ||||||
Ki | POSITIVE ALLOSTERIC MODULATOR | |||||
Ki | POSITIVE ALLOSTERIC MODULATOR | |||||